EUS/IDUS and endoscopic papillectomy

Yoshiki Hirooka, Akihiro Itoh, Hidemi Goto

研究成果: Article査読

24 被引用数 (Scopus)

抄録

In our institute, the indication of endoscopic papillectomy is set for adenoma or early cancer without tumor growth in the bile duct or the pancreatic duct. The substantial complete excision rate was 78.8%. One out of 11 incomplete excision cases was removed surgically for tumor persistence, and, as for remaining the 10 cases without persistence had been under serial observations. One case out of the serial observations had local recurrence in 5 years 5 months after papillectomy and surgical resection was performed. Further cases and long-term serial observations may be required to get evidence of an appropriate indication. In addition, for 60 cases experienced in our institute, the safety of this therapy was reviewed. We experienced bleeding (13.3%), pancreatitis (10%), and cholangitis (3.3%) as early complications, but all cases were successfully treated conservatively. There were no serious conditions as late complications, and endoscopic papillectomy was evaluated as a safe therapy.

本文言語English
ページ(範囲)S176-S177
ジャーナルDigestive Endoscopy
16
SUPPL. 2
DOI
出版ステータスPublished - 20-12-2004
外部発表はい

All Science Journal Classification (ASJC) codes

  • 放射線学、核医学およびイメージング
  • 消化器病学

フィンガープリント

「EUS/IDUS and endoscopic papillectomy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル